Literature DB >> 21035571

Surface plasmon resonance study on functional significance of clustered organization of lectin-like oxidized LDL receptor (LOX-1).

Izuru Ohki1, Hirokazu Amida, Risato Yamada, Mamoru Sugihara, Tomoko Ishigaki, Shin-ichi Tate.   

Abstract

Lectin-like oxidized low-density lipoprotein (OxLDL) receptor 1 (LOX-1) is the major OxLDL receptor of vascular endothelial cells and is involved in an early step of atherogenesis. LOX-1 exists as a disulfide-linked homodimer on the cell surface, which contains a pair of the ligand-binding domains (CTLD; C-type lectin-like domain). Recent research using living cells has suggested that the clustered state of LOX-1 dimer on the cell is functionally required. These results questioned how LOX-1 exists on the cell to achieve OxLDL binding. In this study, we revealed the functional significance of the clustered organization of the ligand-binding domain of LOX-1 with surface plasmon resonance. Biotinylated CTLD was immobilized on a streptavidin sensor chip to make CTLD clusters on the surface. In this state, the CTLD had high affinity for OxLDL with a dissociation constant (K(D)) in the nanomolar range. This value is comparable to the K(D) measured for LOX-1 on the cell. In contrast, a single homodimeric LOX-1 extracellular domain had lower affinity for OxLDL in the supra-micromolar range of K(D). Monomeric CTLD showed marginal binding to OxLDL. In combination with the analyses on the loss-of-binding mutant W150A, we concluded that the clustered organization of the properly formed homodimeric CTLD is essential for the strong binding of LOX-1 to OxLDL.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21035571     DOI: 10.1016/j.bbapap.2010.10.006

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

1.  The lectin-like oxidized LDL receptor-1: a new potential molecular target in colorectal cancer.

Authors:  Michela Murdocca; Ruggiero Mango; Sabina Pucci; Silvia Biocca; Barbara Testa; Rosamaria Capuano; Roberto Paolesse; Massimo Sanchez; Augusto Orlandi; Corrado di Natale; Giuseppe Novelli; Federica Sangiuolo
Journal:  Oncotarget       Date:  2016-03-22

2.  Molecular mechanism of statin-mediated LOX-1 inhibition.

Authors:  Silvia Biocca; Federico Iacovelli; Sara Matarazzo; Giulia Vindigni; Francesco Oteri; Alessandro Desideri; Mattia Falconi
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

3.  Homodimerization of the Lymph Vessel Endothelial Receptor LYVE-1 through a Redox-labile Disulfide Is Critical for Hyaluronan Binding in Lymphatic Endothelium.

Authors:  Suneale Banerji; William Lawrance; Clive Metcalfe; David C Briggs; Akira Yamauchi; Omer Dushek; P Anton van der Merwe; Anthony J Day; David G Jackson
Journal:  J Biol Chem       Date:  2016-10-12       Impact factor: 5.157

4.  Ecrg4 peptide is the ligand of multiple scavenger receptors.

Authors:  Tetsuo Moriguchi; Shuji Takeda; Shinzo Iwashita; Kei Enomoto; Tatsuya Sawamura; Uichi Koshimizu; Toru Kondo
Journal:  Sci Rep       Date:  2018-03-06       Impact factor: 4.379

5.  Unveiling LOX-1 receptor interplay with nanotopography: mechanotransduction and atherosclerosis onset.

Authors:  Carmine Di Rienzo; Emanuela Jacchetti; Francesco Cardarelli; Ranieri Bizzarri; Fabio Beltram; Marco Cecchini
Journal:  Sci Rep       Date:  2013-01-25       Impact factor: 4.379

6.  Membrane Cholesterol Modulates LOX-1 Shedding in Endothelial Cells.

Authors:  Magda Gioia; Giulia Vindigni; Barbara Testa; Sofia Raniolo; Giovanni Francesco Fasciglione; Massimiliano Coletta; Silvia Biocca
Journal:  PLoS One       Date:  2015-10-23       Impact factor: 3.240

Review 7.  LOX-1 and cancer: an indissoluble liaison.

Authors:  M Murdocca; C De Masi; S Pucci; R Mango; G Novelli; C Di Natale; F Sangiuolo
Journal:  Cancer Gene Ther       Date:  2021-01-05       Impact factor: 5.854

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.